Skip to Main Content

Paper Details

Utilization of Filgrastim and Infliximab Biosimilar Products in Medicare Part D, 2015-2019.
JAMA Netw Open
0
2022
Author NameAffiliation
George Caleb AlexanderJohns Hopkins Bloomberg School of Public Health
George Caleb AlexanderCenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health
George Caleb AlexanderJohns Hopkins Bloomberg School of Public Health
George Caleb AlexanderJohns Hopkins Medicine
  • 1 - 4

Datasets

Release 1.2